US-based healthcare technology firm SentiAR has received a new grant from the National Institutes for Health (NIH) for further research on its augmented reality (AR) software to allow better visualisation during cardiac surgeries and additional interventional procedures.

The $2.2m of milestone-based instalments are intended to advance the AR platform for providing clear, real-time control of virtual and real worlds to physicians.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This three-dimensional (3D) visualisation platform features a head-up display and uses real-time navigation feed to generate a holographic display of patient-specific anatomy.

The capability of the technology to facilitate visualisation, measuring and manipulation of real-time holographic images during medical procedures is expected to minimise operating time and radiation exposure to clinicians, and improve outcomes for patients.

“By improving the visualisation of this information and empowering the physician with direct control of the model, we will make these procedures both simpler and safer.”

SentiAR chief medical officer Dr Jennifer Silva said: “Our goal is to provide physicians who perform cardiac ablation procedures with a patient-specific hologram of the heart and the instruments that they are using inside of it.

“By improving the visualisation of this information and empowering the physician with direct control of the model, we will make these procedures both simpler and safer.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“Knowing that our peers – cardiologists and engineers – see the value of our solution and the potential impact it will have for both patients and practitioners is tremendous validation for SentiAR’s model.”

According to the firm’s CEO Jim Howard, the technology could impact approximately one million arrhythmia patients per year and is anticipated to address the existing intraprocedural visualisation challenges.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact